Brimonidine Tartrate And Timolol Maleate NDC 71921-188

NDC codes

FDA NDC Directory

Product NDC (as listed)71921-188Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71921-0188Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71921-188-05	71921018805	1 BOTTLE, DROPPER in 1 CARTON (71921-188-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Nov 23, 2023
71921-188-10	71921018810	1 BOTTLE, DROPPER in 1 CARTON (71921-188-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from Nov 23, 2023
71921-188-15	71921018815	1 BOTTLE, DROPPER in 1 CARTON (71921-188-15) / 15 mL in 1 BOTTLE, DROPPERMarketed from Nov 23, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brimonidine Tartrate And Timolol Maleate
Generic name (nonproprietary): brimonidine tartrate and timolol maleate
Active ingredients: Brimonidine tartrate — 2 mg/mLTimolol maleate — 5 mg/mL
Dosage form: Solution
Route: Ophthalmic
Labeler: Florida Pharmaceutical Products, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201949
Marketing start: Nov 23, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 71921-188_41d7b9be-f2ee-4cb5-ae7e-dcb281591b53SPL ID 41d7b9be-f2ee-4cb5-ae7e-dcb281591b53SPL set ID 7011a203-46cf-434d-ba11-253f107ff80fRxCUI 861635UNII 4S9CL2DY2H, P8Y54F701RUPC 0371921188055
Pharmacologic class: alpha-Adrenergic Agonist; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471921018805 followed by a unit qualifier and the quantity

Package 71921-0188-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2026.

Indications (excerpt from the label)

Brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. Brimonidine tartrate/timolol maleate combination of brimonidine tartrate, an alpha-adrenergic receptor agonist, and timolol malea…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201949

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201949
Product	Strength	Form · route	Labeler	Product NDC
Brimonidine tartrate and Timolol maleate	Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL	Solution/ dropsOphthalmic	NorthStar RxLLC	72603-931
Brimonidine Tartrate/Timolol Maleatebrimonidine tartrate and timolol maleate	Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL	Solution/ dropsOphthalmic	ARMAS PHARMACEUTICALS INC	72485-634